Comparative Study of Crisaborole vs. Tacrolimus in Atopic Dermatitis

Crisaborole 2% Versus Tacrolimus 0.03% Ointments for the Treatment of Mild to Moderate Atopic Dermatitis: A Comparative Study

This study will compare the efficacy and safety of crisaborole ointment with tacrolimus ointment, in the treatment of patients with mild-to-moderate atopic dermatitis.

Inclusion Criteria:

• Patients with diagnosis of AD, according to Hanifin and Rajka criteria.
• Patients of both genders
• Age 5-25 years
• Baseline Investigator's Static Global Assessment (ISGA) score of mild (2) or moderate (3).

Exclusion Criteria:

• Clinically infected eczema.
• Baseline Investigator's Static Global Assessment (ISGA) score of severe (4).
• Associated comorbidities that exacerbate pruritus.
• Patients receiving topical treatment for AD and/or pruritus within the past 14 days and/or systemic treatment within the past month.
• Pregnancy and lactation if in the childbearing period